Evidence map›Paper›PMID 35051413›Full record

ArticleJournal of lipid research2022

Conformational flexibility of apolipoprotein A-I amino- and carboxy-termini is necessary for lipid binding but not cholesterol efflux.

Shimpi Bedi, Jamie Morris, Amy Shah, Rachel C Hart, W Gray Jerome, Stephen G Aller, Chongren Tang, Tomas Vaisar, Karin E Bornfeldt, Jere P Segrest and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of lipid research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Shimpi BediDepartment of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, OH, USA.
Jamie MorrisDepartment of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, OH, USA.
Amy ShahDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Rachel C HartDepartment of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN, USA.
W Gray JeromeDepartment of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN, USA.
Stephen G AllerDepartment of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, AL, USA.
Chongren TangDepartment of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
Tomas VaisarDepartment of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
Karin E BornfeldtDepartment of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
Jere P SegrestDepartment of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.
Jay W HeineckeDepartment of Medicine, University of Washington School of Medicine, Seattle, WA, USA.
W Sean DavidsonDepartment of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, OH, USA. Electronic address: Sean.Davidson@UC.edu.
University of Washington · USUniversity of Cincinnati · USVanderbilt University · USCincinnati Children's Hospital Medical Center · USUniversity of Alabama at Birmingham · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI STACIE B DUSETZINA · 1995 to 2026
$172.8M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ALVIN C POWERS · 2012 to 2026
$29.3M
Project 3 - HDL Structure/Function in LCAT Deficient HumansP01HL128203 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI W Sean Davidson · 2016 to 2026
$25.1M
Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI David J. Calkins · 1989 to 2026
$19.6M
Triglycerides, Diabetes and Cardiovascular DiseaseP01HL151328 · NHLBI · UNIVERSITY OF WASHINGTON · PI Karin E Bornfeldt · 2020 to 2026
$19.6M
Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
Identifying new strategies for prevention of cardiovascular complications of diabetesR35HL150754 · NHLBI · UNIVERSITY OF WASHINGTON · PI BORNFELDT, KARIN E · 2020 to 2025
$6.2M
HDL composition/function and cardiovascular risk in youths with diabetesR01HL144558 · NHLBI · UNIVERSITY OF WASHINGTON · PI VAISAR, TOMAS · 2019 to 2022
$2.8M
Structural basis for cardioprotective HDLR01HL149685 · NHLBI · UNIVERSITY OF WASHINGTON · PI BORNFELDT, KARIN E., HEINECKE, JAY W · 2020 to 2023
$2.8M
The structural basis for cholesterol esterification in human plasmaR01HL153118 · NHLBI · UNIVERSITY OF CINCINNATI · PI DAVIDSON, W SEAN · 2020 to 2023
$2.0M
NCI NIH HHS P30 CA068485NEI NIH HHS P30 EY008126NHLBI NIH HHS P01 HL128203NHLBI NIH HHS P01 HL151328NHLBI NIH HHS R01 HL144558NHLBI NIH HHS R01 HL149685NHLBI NIH HHS R01 HL153118NHLBI NIH HHS R35 HL150754NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P30 DK058404NIDDK NIH HHS U24 DK059637
6 · The paper itself

Abstract

Because of its critical role in HDL formation, significant efforts have been devoted to studying apolipoprotein A-I (APOA1) structural transitions in response to lipid binding. To assess the requirements for the conformational freedom of its termini during HDL particle formation, we generated three dimeric APOA1 molecules with their termini covalently joined in different combinations. The dimeric (d)-APOA1C-N mutant coupled the C-terminus of one APOA1 molecule to the N-terminus of a second with a short alanine linker, whereas the d-APOA1C-C and d-APOA1N-N mutants coupled the C-termini and the N-termini of two APOA1 molecules, respectively, using introduced cysteine residues to form disulfide linkages. We then tested the ability of these constructs to generate reconstituted HDL by detergent-assisted and spontaneous phospholipid microsolubilization methods. Using cholate dialysis, we demonstrate WT and all APOA1 mutants generated reconstituted HDL particles of similar sizes, morphologies, compositions, and abilities to activate lecithin:cholesterol acyltransferase. Unlike WT, however, the mutants were incapable of spontaneously solubilizing short chain phospholipids into discoidal particles. We found lipid-free d-APOA1C-N and d-APOA1N-N retained most of WT APOA1's ability to promote cholesterol efflux via the ATP binding cassette transporter A1, whereas d-APOA1C-C exhibited impaired cholesterol efflux. Our data support the double belt model for a lipid-bound APOA1 structure in nascent HDL particles and refute other postulated arrangements like the "double super helix." Furthermore, we conclude the conformational freedom of both the N- and C-termini of APOA1 is important in spontaneous microsolubilization of bulk phospholipid but is not critical for ABCA1-mediated cholesterol efflux.

Indexed as

Apolipoprotein A-ICholesterolATP Binding Cassette Transporter 1Biological TransportPhosphatidylcholine-Sterol O-AcyltransferasePhospholipidsApolipoprotein A-IATP Binding Cassette Transporter 1CholesterolPhosphatidylcholine-Sterol O-AcyltransferasePhospholipidsapolipoprotein A-IATP binding cassette transporter ABCA1cholate dialysischolesterol effluxdouble belt modelelectron microscopyhigh-density lipoproteinlecithin:cholesterol acyltransferasemultilamellar vesiclesspontaneous phospholipid microsolubilization

Identifiers

PMID35051413
PMCPMC8953623
OpenAlexW4205550958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.